Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
8.98
-0.02 (-0.22%)
Nov 22, 2024, 4:00 PM EST - Market closed
Actuate Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -28.45 | -24.74 | -20.16 |
| Stock-Based Compensation | 0.93 | 0.42 | 0.65 |
| Other Operating Activities | 2.4 | 0.12 | -0.02 |
| Change in Accounts Payable | -0.33 | 1.29 | 0.59 |
| Change in Other Net Operating Assets | 2.88 | 1.28 | 1.15 |
| Operating Cash Flow | -22.58 | -21.63 | -17.79 |
| Financing Cash Flow | 27.64 | 4.13 | 19.26 |
| Net Cash Flow | 5.05 | -17.49 | 1.46 |
| Free Cash Flow | -22.58 | -21.63 | -17.79 |
| Free Cash Flow Per Share | -5.85 | -15.07 | -14.70 |
| Levered Free Cash Flow | - | -12.64 | - |
| Unlevered Free Cash Flow | - | -12.61 | - |
| Change in Net Working Capital | - | -2.57 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.